
Innovation versus Financialization in the US Pharmaceutical Industry
The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends and stock buybacks; (c) do not rely on investment by shareholders; and (d) benefit from 'collectiv......
fra 269,-
Tilgjengelig i 1 butikker
Frakt og levering
Produktinformasjon
The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends and stock buybacks; (c) do not rely on investment by shareholders; and (d) benefit from 'collective and cumulative learning.'
Topplisten: Other Brand Økonomi og ledelse

Getting to Yes
65,-
3
Spesifikasjon
Produkt
| Produktnavn | Innovation versus Financialization in the US Pharmaceutical Industry |
| Merke | Other Brand |
Populære produkter
Pris og prishistorikk
Akkurat nå er 269,- den billigste prisen for Innovation versus Financialization in the US Pharmaceutical Industry blant 1 butikker hos Prisradar. Sjekk også vår topp 5-rangering av beste økonomi og ledelse for å være sikker på at du gjør det beste kjøpet.
Luxury Wine MarketingInnovation versus Financialization in the US Pharmaceutical IndustryDie Bilanzierung Von Leasingvertraegen Nach IascNew Dimensions in Regional Integration
APPLIED MANAGEMNT ACCOUNTING STUDY TEXTGreening the International Monetary FundOekonomische Aspekte Der Freiwilligen MitarbeiterbeteiligungThe Theory of the Firm
FINAICLA ACCOUNTING:PREPARING FINANCIAL STATEMENTSTUDY TEXTUnderstanding Context in LeadershipGreening the International Monetary FundDas Fehlerrisiko Eines Handelsrechtlichen Jahresabschlusses









